Using novel technology platforms for biomarker discovery
and the development of new vaccine and therapeutic strategies.
On the occasion of the Chinese New Year, the Centre for Immunology & Infection (C2i) wishes you a happy and prosperous Year of the Tiger and is very proud to launch its first Newsletter, presenting the work of a team fully dedicated to
the betterment of science and public health.
Countries Primarily Using CoronaVac Vaccines Should Consider mRNA Vaccine Boosters to face Omicron
Malik Peiris signed with Leo Poon a new publication in Nature Medicine suggesting that countries primarily using CoronaVac vaccines should consider mRNA vaccine boosters.
Malik Peiris finds Omicron significantly reduces virus neutralisation ability of BioNTech vaccine
A recent study jointly conducted by HKUMed and Cu Medicine has revealed that Omicron can significantly reduce the virus neutralisation ability of Pfizer BioNTech vaccine by 32 folds or more.
Omicron variant can multiply 70 times faster than other strains in lower respiratory tracts of hosts
South China Morning Post reports Michael Chan and team findings and warns the overall threat could be ‘very significant’, although there could be lower infection severity.
Electron Microscope Image of the SARS-CoV-2 Omicron Variant
Prof Malik Peiris, Managing Director at C2i and Prof John Nicholls from the Department of Pathology at HKU have released an electron microscope image of the SARS-CoV-2 Omicron variant.
